Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6733-6740

  Smith, Colton A ^a   Woodruff, Linda S ^a   Kitchingman, Geoffrey R ^a   Rooney, Cliona M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; VIRUS PROTEIN;

ADENOVIRUS; ANTIGEN PRESENTING CELL; ARTICLE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0029793811     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6733-6740.1996     Document Type: Article

References (42)

1. Andersen, C. W., P. R. Baum, and R. F. Gesteland. 1973. Processing of adenovirus 2-induced proteins. J. Virol. 12:241-252.
2. Bailey, A., and V. Mautner. 1994. Phylogenctic relationships among adenovirus serotypes. Virology 205:438-452.
3. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 304:3862-3871.
4. + cytolytic T cell responses. J. Exp. Med. 182:1663-1671.
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. Chroboczek, J., F. Bieger, and B. Jacrol. 1992. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280-285.
7. Defer, C., M.-T. Belin, M.-L. Caillet-Boudin, and P. Boulanger. 1990. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64:3661-3673.
8. Evans, A. S. 1958. Latent adenovirus infections of the human respiratory tract. Am. J. Hyg. 67:256-263.
9. Flomenberg, P., J. Babbitt, W. R. Drobyski, R. C. Ash, D. R. Carrigan, G. V. Sedmak, T. McAuliffe, B. Camitta, M. M. Horowitz, N. Bunin, and J. T. Casper. 1994. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169:775-781.
10. Flomenberg, P., V. Piaskowski, R. L. Truitt, and J. T. Casper. 1995. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 171:1090-1096.
11. Gooding, L. R., and W. S. M. Wold. 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit. Rev. Immunol. 10:53-71.
12. Hill, A., and H. Ploegh. 1995. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc. Natl. Acad. Sci. USA 92:341-343.
13. Horwitz, M. 1990. Adenoviridae and their replication, p. 1679-1721. In B. N. Fields (ed.), Virology, vol. 2. Raven Press, New York.
14. Hromas, R., K. Cornetta, E. Srour, C. Blanke, and E. R. Broun. 1994. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84:1689-1690.
15. Huang, S., R. I. Endo, and G. R. Nemerow. 1995. Upregulation of integrins αvβ3 and αvβ5 on human monocytes and T lymphocytes facilitates adenovirus-mediatcd gene delivery. J. Virol. 69:2257-2263.
16. Kitchingman, G. R. 1995. Mutations in the adenovirus encoded single-stranded DNA binding protein that result in altered accumulation of early and late viral RNAs. Virology 212:91-101.
17. Mathias, P., T. Wickham, M. Moore, and G. Nemerow. 1994. Multiple adenovirus serotypes use αv integrins for infection. J. Virol. 68:6811-6814.
18. Müllbacher, A., A. J. D. Bellett, and R. T. Hla. 1989. The murine cellular response to adenovirus type 5. Immunol. Cell Biol. 67:31-39.
19. Neumann, R., E. Generesch, and H. Eggers. 1987. Detection of adenovirus nucleic acid sequences in human tonsils in the absence of infectious virus. Virus Res. 7:93-97.
20. Papadopoulos, E. B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. N. Small, J. W. Young, N. A. Kernan, and R. J. O'Reilly. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330: 1185-1191.
21. Pereira, D. S., K. L. Rosenthal, and F. L. Graham. 1995. Identification of adenovirus EIA regions which affect MHC class I expression and susceptibility to cytotoxic T lymphocytes. Virology 211:268-277.
22. Rawle, F. C., B. B. Knowles, R. P. Ricciardi, V. Brahmacheri, P. Duerksen-Hughes, W. S. M. Wold, and L. R. Gooding. 1991. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. J. Immunol. 146:3977-3984.
23. Riddell, S. R., M. Rabin, A. P. Geballe, W. J. Britt, and P. D. Greenberg. 1991. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogeneous viral gene expression. J. Immunol. 146:2795-2804.
24. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241.
25. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180: 83-93.
26. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A. M. Livingstone, C. G. Fathman, K. Inaba, and R. M. Steinman. 1989. Presentation of exogeneous protein antigens by dendritic cells to T cell clones. J. Exp. Med. 169:1169-1174.
27. Rooney, C. M., C. A. Smith, C. Y. C. Ng, S. K. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9-12.
28. Routes, J. M., D. Bellgrau, W. J. McGrory, D. S. Bautista, F. L. Graham, and J. L. Cook. 1991. Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1a gene. J. Virol. 65:1450-1456.
29. Routes, J. M., and J. L. Cook. 1990. Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression. J. Immunol. 144: 2763-2770.
30. Routes, J. M., and J. L. Cook. 1995. E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells. Virology 210:421-428.
31. Routes, J. M., B. A. Metz, and J. L. Cook. 1993. Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression. J. Virol. 67:3176-3181.
32. Schmitz, H., R. Wigand, and W. Heinrich. 1983. Worldwide epidemiology of human adenovirus infections. Am. J. Epidemiol. 117:455-466.
33. Smith, C. A., C. Y. C. Ng, H. E. Heslop, M. S. Holladay, S. Richardson, S. K. Loftin, V. E. Turner, M. K. Brenner, and C. M. Rooney. 1995. Production and administration of genetically modified EBV-specific cytotoxic T to recipients of allogeneic bone marrow transplantation. Br. J. Haematother. 4:73-79.
34. Souberbielle, B. E., and W. C. Russell. 1995. Human T cell proliferative response to polypeplides from adenovirus type 2. J. Infect. Dis. 172:1421-1422.
35. Stevenson, S. C., M. Rollence, B. White, L. Weaver, and A. McClelland. 1995. Human adenovirus serotypes 3 and 5 bind to two different receptors via the fiber head domain. J. Virol. 69:2850-2857.
36. + herpes simplex virus-specific cytotoxic T-lymphocyle clones recognize diverse virion protein antigens. J. Virol. 66:1622-1634.
37. Wadell, G., M. L. Hammarskjold, G. Winberg, T. M. Varsanyi, and G. Sundell. 1980. Genetic variability of adenoviruses. Ann. N.Y. Acad. Sci. 354:16-42.
38. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
39. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
40. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1-8.
41. Yang, Y., F. A. Nunes, K. Berencsi, E. Gönezöl, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7:362-369.
42. Yang, Y., Z. Xiang, H. C. J. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.